Beyond the Ribose Ring: Cosperpharma’s PMO Phosphoramidites for Advanced Splice-Switching Therapeutics

Product List

About the Product

PMO chemistry represents a fundamental departure from traditional nucleic acid structures. The uncharged phosphorodiamidate backbone eliminates the electrostatic repulsion found in natural DNA/RNA, leading to stronger and more predictable binding to target RNA. Furthermore, the morpholine ring protects the oligomer from degradation by nucleases and reduces interactions with cellular proteins. Cosperpharma’s PMO subunits are synthesized under rigorously controlled conditions, utilizing specialized protecting groups (such as the O(6)-NPE and N(2)-iBu groups for Guanine) to ensure high coupling efficiency and the generation of high-quality PMO oligomers for research and therapeutic development.

Applications

Cosperpharma’s PMO subunits are essential tools for a variety of advanced oligonucleotide applications:

Splice-Switching Therapy: Modulating pre-mRNA splicing to restore functional protein expression in genetic disorders (e.g., Duchenne muscular dystrophy).

Translation Blocking: Inhibiting the translation of specific mRNA targets by steric hindrance, reducing pathogenic protein levels.

Antisense Therapeutics: Developing highly stable, neutrally charged antisense drugs with extended in vivo half-lives.

Basic Research: Investigating RNA function and regulation without inducing RNase H-mediated cleavage.

Contact Us

We are dedicated to supporting your advanced oligonucleotide research with the highest quality PMO subunits. If you are interested in evaluating our Morpholino phosphoramidites or would like to discuss your specific synthesis challenges with our technical team, we invite you to connect with us. Contact Cosperpharma today to request a detailed specification sheet, explore our latest batch data, or receive a customized quotation for your next project.